Table 4.
Effect of SCEE on insulin, glucose, haemoglobin, and glycosylated hemoglobin level in alloxan induced diabetic animal.
| Group | Glucose (mg/dL) | Insulin (U/L) | Haemoglobin (g/dL) | Gly. haemoglobin (%) |
|---|---|---|---|---|
| Normal control | 83.6 ± 4.0d | 15.0 ± 1.0a | 12.6 ± 0.6a | 1.5 ± 0.1f |
| Diabetic + glibenclamide | 92.0 ± 2.0cd | 13.1 ± 1.0ab | 10.3 ± 0.5b | 1.8 ± 0.1ef |
| Diabetic control | 241.6 ± 7.6a | 6.0 ± 1.0e | 5.8 ± 0.3c | 4.3 ± 0.4a |
| Diabetic + SCEE 150 mg/kg | 129.3 ± 5.3b | 10.0 ± 1.0cd | 10.6 ± 0.5ab | 3.1 ± 0.1c |
| Diabetic + SCEE 300 mg/kg | 95.6 ± 3.5cd | 12.5 ± 0.5b | 12.0 ± 1.0ab | 2.1 ± 0.1e |
Values expressed as means ± SD. Means ± SD with different superscript letters (a–d) within the column indicate significant difference (P < 0.05). SCEE: S. cordata ethyl acetate fraction.